IDH1 and neoplasm: More caregivers of patients with concurrent mMGMT and IDH1 mutation–positive tumor status reported performing tasks related to “medication organization/administration” compared with patients with concurrent uMGMT and IDH1 mutant tumor status (77% vs 20%, p = 0.047).